{"id":468469,"date":"2021-03-31T08:03:31","date_gmt":"2021-03-31T12:03:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=468469"},"modified":"2021-03-31T08:03:31","modified_gmt":"2021-03-31T12:03:31","slug":"agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/","title":{"rendered":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">GAINESVILLE, Fla. and CAMBRIDGE, Mass., March  31, 2021  (GLOBE NEWSWIRE) &#8212; Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Company management will participate in the following virtual conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Wells Fargo Biotech Corporate Access Day (April 6, 2021)<br \/><\/strong>Sue Washer, President &amp; Chief Executive Officer, and Bill Sullivan, Chief Financial Officer, will host investor one-on-one and small group meetings. For more information, please contact your Wells Fargo representative.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Alliance for Regenerative Medicine Cell &amp; Gene Meeting on the Mediterranean (April 6-9, 2021)<br \/><\/strong>An AGTC corporate update by Ms. Washer and Mark Shearman, PhD, Chief Scientific Officer, will be available for registered attendees to view on-demand throughout the entirety of the conference. Please visit <a href=\"http:\/\/www.meetingonthemed.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.meetingonthemed.com<\/a> for full information including registration.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About AGTC<br \/><\/strong>AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC\u2019s most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company\u2019s industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.<\/p>\n<p>\n        <strong>IR\/PR Contacts:<\/strong><br \/>\n        <br \/>David Carey\u00a0(IR) or\u00a0Glenn Silver\u00a0(PR)<br \/>Lazar FINN Partners<br \/>T: (212) 867-1768 or (646) 871-8485<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ckUloO9RuecQAlbmtPgZq4ALmKyvDG8me0Pgo-Puv0IuzmAsKBFXB07WxW4Qa0fPGcgPb2YbsPqc414-lTSyjXT5iJoCfXr8GYe66IHQO1ZE7rXk1pUqf-mHs7Y-ZqWH\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">david.carey@finnpartners.com<\/a>\u00a0or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DytAeiLsUUvgxt9PvYCM3Q1vWN9oK5vvkjdzg0RalcgGkZJ2SK1llj1Q8fqsr5J6qOdKVk6GQPFJ1YmKKoWl2rlk-ilP9Jc84u6rO70GVClvgc0G_NL_JsZLHQQjVacN\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">glenn.silver@finnpartners.com<\/a><\/p>\n<p>\n        <strong>Corporate Contacts:<\/strong><br \/>\n        <br \/>Bill Sullivan<br \/>Chief Financial Officer<br \/>Applied Genetic Technologies Corporation<br \/>T: (617) 843-5728<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z7Vz2SQwxFRroZ-81ysqSCiVFpL9EfsghLYDp98RWGu9_WJkkoauOOUgeauk4jIGwSo-X-vErsT81j0kprhqeQkGJ5y4d9ztvIvdBS8zJgE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>bsullivan@agtc.com<\/u><\/a><\/p>\n<p>Stephen Potter<br \/>Chief Business Officer<br \/>Applied Genetic Technologies Corporation<br \/>T: (617) 413-2754<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yZyCFfTFfAfyCJmIM4ZM1GcSatYbyQWqjz43vi3yPnYzdskFVg9u0W3-yDmM_6ftPd4LX2X2qaJrE5xEHk1CKA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">spotter@agtc.com<\/a><\/u>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/930ca186-f6f8-411f-b31a-078fba0be52b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) &#8212; Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Company management will participate in the following virtual conferences: Wells Fargo Biotech Corporate Access Day (April 6, 2021)Sue Washer, President &amp; Chief Executive Officer, and Bill Sullivan, Chief Financial Officer, will host investor one-on-one and small group meetings. For more information, please contact your Wells Fargo representative. Alliance for Regenerative Medicine Cell &amp; Gene Meeting on the Mediterranean (April 6-9, 2021)An AGTC corporate update by Ms. Washer and Mark Shearman, PhD, Chief Scientific Officer, will be available for registered attendees to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-468469","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) &#8212; Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Company management will participate in the following virtual conferences: Wells Fargo Biotech Corporate Access Day (April 6, 2021)Sue Washer, President &amp; Chief Executive Officer, and Bill Sullivan, Chief Financial Officer, will host investor one-on-one and small group meetings. For more information, please contact your Wells Fargo representative. Alliance for Regenerative Medicine Cell &amp; Gene Meeting on the Mediterranean (April 6-9, 2021)An AGTC corporate update by Ms. Washer and Mark Shearman, PhD, Chief Scientific Officer, will be available for registered attendees to &hellip; Continue reading &quot;AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-31T12:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference\",\"datePublished\":\"2021-03-31T12:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/\",\"name\":\"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\",\"datePublished\":\"2021-03-31T12:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/","og_locale":"en_US","og_type":"article","og_title":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk","og_description":"GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) &#8212; Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Company management will participate in the following virtual conferences: Wells Fargo Biotech Corporate Access Day (April 6, 2021)Sue Washer, President &amp; Chief Executive Officer, and Bill Sullivan, Chief Financial Officer, will host investor one-on-one and small group meetings. For more information, please contact your Wells Fargo representative. Alliance for Regenerative Medicine Cell &amp; Gene Meeting on the Mediterranean (April 6-9, 2021)An AGTC corporate update by Ms. Washer and Mark Shearman, PhD, Chief Scientific Officer, will be available for registered attendees to &hellip; Continue reading \"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-31T12:03:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference","datePublished":"2021-03-31T12:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/","name":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=","datePublished":"2021-03-31T12:03:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwODc3MyM0MDk4MzMxIzIwMDUwMzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and-gene-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and\u00a0Cell and Gene Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/468469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=468469"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/468469\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=468469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=468469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=468469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}